Recommend Cancer Biology & Therapy to your librarian for 2008. Download the form here.

Sign up for Table of Contents Alerts.

home subscribe search archive forthcoming

Email this page Print this page

Research Paper

Contributing Factors of Temozolomide Resistance in MCF-7 Tumor Xenograft Models

Yoshinori Kato, Baasil Okollie, Venu Raman, Farhad Vesuna, Ming Zhao, Sharyn D. Baker, Zaver M. Bhujwalla and Dmitri Artemov

volume 6 | issue 6

June 2007


We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:

 Download PDF

If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.

Vasculature mediated drug resistance in tumors was studied in female SCID mice bearing wild type MCF-7 and adriamycin resistant MCF-7/ADR xenograft using temozolomide (TMZ). A strong tumor growth inhibitory effect of TMZ treatment was 5 observed in MCF-7 tumors during the initial treatment phase with subsequent relapse, but not in MCF-7/ADR tumors. Non-invasive MRI measurements of tumor vascular volume and vascular permeability-surface area product (PS) demonstrated significant reduction of PS in long-term treated MCF-7, but not in MCF-7/ADR tumors. O6-Methylguanine-DNA methyltransferase (MGMT) mRNA, and VEGF expression 10 was analyzed using real-time RT-PCR and ELISA, respectively. No significant changes in MGMT mRNA and VEGF expression were observed in either MCF-7 or MCF-7/ADR tumors. However, in vitro incubation of MCF-7 cells with TMZ did induce the expression of MGMT mRNA. In addition, p53 and p21 levels were scored by immunoblotting. Exposure of cells to TMZ did not affect either the p21 or 15 the p53 expression in both MCF-7 and MCF-7/ADR cells. The absence of these molecular responses to TMZ treatment in MCF-7 tumors in vivo supports the possibility that the onset of cancer drug resistance is associated with reduced PS, which can decrease the delivery of the drug to the cancer cells.

Authors

Yoshinori Kato

The Johns Hopkins University School of Medicine, Baltimore, MD USA

Baasil Okollie

The Johns Hopkins University School of Medicine, Baltimore, MD USA

Venu Raman

Johns Hopkins University, School of Medicine; Baltimore MD USA

Farhad Vesuna

Johns Hopkins University, School of Medicine; Baltimore MD USA

Ming Zhao

Johns Hopkins University, School of Medicine; Baltimore MD USA

Sharyn D. Baker

Johns Hopkins University, School of Medicine; Baltimore MD USA

Zaver M. Bhujwalla

Johns Hopkins University, School of Medicine; Baltimore MD USA

Dmitri Artemov

Johns Hopkins University, School of Medicine; Baltimore MD USA




We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:

 Download PDF

If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.